Current Applied Polymer Science,
Journal Year:
2023,
Volume and Issue:
6(1), P. 2 - 13
Published: April 1, 2023
Abstract:
Nanotechnology
augmentation
have
enabled
the
creation
of
innovative
colloidal
preparations
that
can
modify
pharmacological
characteristics
medications.
Numerous
effective
applications
in
treatment
cancer
been
made
possible
by
distinctive
physicochemical
and
technological
therapies
based
on
nanomaterials.
To
facilitate
maximize
interaction
between
cells
tissues,
it
is
necessary
to
examine
size,
shape,
charge,
patterning
nanoscale
therapeutic
molecules.
The
flavonoids
chalcones
their
natural
scaffolds
provide
a
variety
biological
effects
crucial
for
creating
medicines.
Plant-based
anticancer
medicines
represent
promising
scientific
business
opportunity
should
be
investigated.
By
using
traditional
Chinese
medicine
(TCM)
therapies,
diseases
avoided,
healthcare
enhanced.
Traditional
safe,
straightforward,
reasonably
priced.
There
are
numerous
treatments
chronic,
geriatric,
incurable
diseases.
Heterocyclic
equivalents
properties.
One
them
its
anti-cancer
properties,
as
result
Chalcones
drawn
huge
interest
study
malignancy.
Licorice
an
essential
primary
ingredient
many
folk
medicines,
including
Mongolian
medicine.
Research
chalcone
with
strong
growth-inhibitory
activity
tumor
cell
lines
was
influenced
rising
this
medicinal
molecule,
papers
these
now
accessible.
It
do
thorough
examination
before
congeners
developed
prodrug
or
chemical
treat
cancer.
create
focused
efficient
drug
delivery
system
treatment,
we
shall
discuss
derivatives
nano-enabled
systems
article.
has
discussed
how
polymeric
nanoparticles
might
effectively
localize
particular
tissues
act
vehicles
drugs
due
characteristics.
A
strategy
increase
effectiveness
various
nanoencapsulation
active
substances
systems.
Pharmaceutics,
Journal Year:
2023,
Volume and Issue:
15(7), P. 1868 - 1868
Published: July 2, 2023
Cancer
immunotherapy
is
an
innovative
treatment
strategy
to
enhance
the
ability
of
immune
system
recognize
and
eliminate
cancer
cells.
However,
dose
limitations,
low
response
rates,
adverse
events
pose
significant
challenges.
To
address
these
gold
nanoparticles
(AuNPs)
have
been
explored
as
immunotherapeutic
drug
carriers
owing
their
stability,
surface
versatility,
excellent
optical
properties.
This
review
provides
overview
advanced
synthesis
routes
for
AuNPs
utilization
improve
precision
therapies.
The
also
emphasises
various
aspects
AuNP-based
immunotherapy,
including
loading,
targeting
strategies,
release
mechanisms.
application
combined
with
therapeutic
efficacy
are
briefly
discussed.
Overall,
we
aimed
provide
a
recent
understanding
advances,
challenges,
prospects
anticancer
applications.
Nanophotonics,
Journal Year:
2024,
Volume and Issue:
13(4), P. 443 - 455
Published: Feb. 2, 2024
Abstract
Upconversion
photodynamic
therapy
(UC-PDT),
which
integrates
upconversion
nanoparticles
(UCNPs)
with
photosensitizers
(PSs),
presents
a
promising
advancement
in
the
field
of
phototherapy.
However,
despite
extensive
studies
focused
on
design
and
synthesis
UCNPs,
there
is
paucity
systematic
research
mechanisms
underlying
synergistic
effects.
Here
we
have
synthesized
core@dotted-shell
(CDSNPs)
covalently
tethered
them
two
distinct
PSs,
thereby
constructing
dual-PS
UC-PDT
system
high
performance.
To
unravel
mechanism
synergism,
employed
combination
quantum
mechanical
calculations
ultrafast
time-resolved
spectroscopy
techniques.
The
results
indicate
that
rare
earth
oxides
play
pivotal
role
enhancing
intersystem
crossing
processes
PSs
through
modulating
their
excited
electronic
states.
Additionally,
Förster
resonance
energy
transfer
between
contributes
to
amplification
triplet
state
populations,
thus
further
effect.
In
vitro
experiments
demonstrate
prepared
CDSNPs
based
exhibits
excellent
biocompatibility
normal
cells
exceptional
efficacy
against
tumor
upon
near-infrared
excitation.
This
theoretical
insights
into
application
multi-photosensitizer
systems,
laying
groundwork
for
more
efficient
preclinical
implementations
future.
Photochemistry and Photobiology,
Journal Year:
2022,
Volume and Issue:
99(2), P. 356 - 419
Published: Sept. 26, 2022
Abstract
This
review
follows
the
research,
development
and
clinical
applications
of
photosensitizer
5,10,15,20‐tetra(
m
‐hydroxyphenyl)chlorin
(
THPC,
temoporfin)
in
photodynamic
(cancer)
therapy
(PDT)
other
medical
applications.
Temoporfin
is
active
substance
medicinal
product
Foscan®
authorized
EU
for
palliative
treatment
head
neck
cancer.
Chemistry,
biochemistry
pharmacology,
as
well
temoporfin
are
addressed,
including
extensive
work
that
has
been
done
on
formulation
liposomal
formulations.
The
literature
covered
from
2009
to
early
2022,
thereby
connecting
it
previous
this
published
journal
[Senge,
M.
O.
J.
C.
Brandt
(2011)
Photochem.
Photobiol.
87,
1240–1296]
which
followed
its
way
initial
approval
application.
Molecules,
Journal Year:
2022,
Volume and Issue:
27(3), P. 778 - 778
Published: Jan. 25, 2022
Singlet
oxygen
(1O2)
is
the
excited
state
of
ground,
triplet
state,
molecular
(O2).
Photosensitized
1O2
has
been
extensively
studied
as
one
reactive
species
(ROS),
responsible
for
damage
cellular
components
(protein,
DNA,
lipids).
On
other
hand,
its
generation
exploited
in
organic
synthesis,
well
photodynamic
therapy
treatment
various
forms
cancer.
The
aim
this
review
to
highlight
versatility
1O2,
discussing
main
bioorganic
applications
reported
over
past
decades,
which
rely
on
production.
After
a
brief
introduction
photosensitized
production
we
will
describe
aspects
involving
biologically
relevant
that
can
accompany
an
uncontrolled,
aspecific
ROS.
We
then
discuss
more
detail
series
biological
featuring
generation,
including
protein
and
DNA
labelling,
cross-linking
biosensing.
Finally,
methodologies
available
tailor
order
accomplish
proposed
transformations
while
avoiding,
at
same
time,
collateral
related
untamed
species.
Pharmaceutics,
Journal Year:
2023,
Volume and Issue:
15(3), P. 971 - 971
Published: March 17, 2023
Radiopharmaceutical
therapy,
which
can
detect
and
treat
tumours
simultaneously,
was
introduced
more
than
80
years
ago,
it
has
changed
medical
strategies
with
respect
to
cancer.
Many
radioactive
radionuclides
have
been
developed,
functional,
molecularly
modified
radiolabelled
peptides
used
produce
biomolecules
therapeutics
that
are
vastly
utilised
in
the
field
of
radio
medicine.
Since
1990s,
they
smoothly
transitioned
into
clinical
application,
as
today,
a
wide
variety
radionuclide
derivatives
examined
evaluated
various
studies.
Advanced
technologies,
such
conjugation
functional
or
incorporation
chelating
ligands,
developed
for
advanced
radiopharmaceutical
cancer
therapy.
New
conjugates
targeted
radiotherapy
designed
deliver
radiation
directly
cells
improved
specificity
minimal
damage
surrounding
normal
tissue.
The
development
new
theragnostic
radionuclides,
be
both
imaging
therapy
purposes,
allows
precise
targeting
monitoring
treatment
response.
increased
use
peptide
receptor
(PRRT)
is
also
important
specific
receptors
overexpressed
cells.
In
this
review,
we
provide
insights
peptides,
give
brief
background,
describe
their
transition
application.
Journal of Materials Chemistry B,
Journal Year:
2024,
Volume and Issue:
12(42), P. 10786 - 10817
Published: Jan. 1, 2024
The
review
highlights
the
potential
of
RGD-conjugated
AuNPs
in
cancer
diagnosis
and
treatment,
including
breast
cancer.
It
emphasizes
need
for
further
research
to
fully
realize
this
technology’s
inspire
future
investigations.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology,
Journal Year:
2023,
Volume and Issue:
16(1)
Published: July 2, 2023
Abstract
Natural
materials
and
bioprocesses
provide
abundant
inspirations
for
the
design
synthesis
of
high‐performance
nanomaterials.
In
past
several
decades,
bioinspired
nanomaterials
have
shown
great
potential
in
application
biomedical
fields,
such
as
tissue
engineering,
drug
delivery,
cancer
therapy,
so
on.
this
review,
three
types
strategies
nanomaterials,
that
is,
inspired
by
natural
structures,
biomolecules,
bioprocesses,
are
mainly
introduced.
We
summarize
discuss
concepts
approaches
various
along
with
their
specific
roles
applications.
Additionally,
we
challenges
development
mechanical
failure
wet
environment,
limitation
scale‐up
fabrication,
lack
deep
understanding
biological
properties.
It
is
expected
clinical
translation
will
be
further
promoted
under
cooperation
interdisciplinary
subjects
future.
This
article
categorized
under:
Implantable
Materials
Surgical
Technologies
>
Nanomaterials
Implants
Therapeutic
Approaches
Drug
Discovery
Emerging
Pharmaceuticals,
Journal Year:
2023,
Volume and Issue:
16(2), P. 143 - 143
Published: Jan. 18, 2023
Cerenkov-induced
photodynamic
therapy
(CR-PDT)
with
the
use
of
Gallium-68
(68Ga)
as
an
unsealed
radioactive
source
has
been
proposed
alternative
strategy
to
X-ray-induced
(X-PDT).
This
new
still
aims
produce
a
effect
nanoparticles,
namely,
AGuIX.
Recently,
we
replaced
Gd
from
AGuIX@
platform
Terbium
(Tb)
nanoscintillator
and
added
5-(4-carboxyphenyl
succinimide
ester)-10,15,20-triphenylporphyrin
(P1)
photosensitizer
(referred
AGuIX@Tb-P1).
Although
Cerenkov
luminescence
68Ga
positrons
is
involved
in
activation,
cytotoxic
obtained
by
PDT
remains
controversial.
Herein,
tested
whether
free
could
substitute
X-rays
X-PDT
obtain
phototherapeutic
effect.
Results
were
compared
those
AGuIX@Gd-P1
nanoparticles.
We
showed,
Monte
Carlo
simulations,
contribution
Tb
scintillation
P1
activation
energy
transfer
between
after
radiation,
Gd-based
confirmed
involvement
type
II
reaction
during
68Ga-mediated
luminescence,
id
est,
photon
AGuIX@Tb-P1
which,
turn,
generated
P1-mediated
singlet
oxygen.
The
on
cell
survival
was
studied
clonogenic
assays
using
human
glioblastoma
U-251
MG
cells.
Exposure
pre-treated
cells
resulted
decrease
clone
formation,
unlike
AGuIX@Gd-P1.
conclude
that
CR-PDT
be
X-PDT.